Mar 16, 2018
CNCR ETF is up about 30% this year; here is what investors need to know about immunotherapy and the ETF (CNCR, IBB)
(1:10) - What Is Immunotherapy?
(4:25) - 5 Types Of FDA Approved Immunotherapy
((7:50) - What Kind Of Cancer Does This Treat?
(9:45) - Loncar Cancer Immunotherapy ETF: CNCR
(17:00) - Cancer Research Institute Partnership
(20:45) - What Is Driving The Positive Performance?
(25:00) - Launch Of China Biotech Index
(27:10) - Episode Roundup: Podcast@Zacks.com